Trial for new epilepsy med

Shortly starting an open label clinical trial to evaluate a new epilepsy drug called vormatrigine, developed by Praxis Precison Meds. It's 14 weeks long, divided into extensive screening, and a number of visits with a great deal of assessments and procedures. Belive this is first phase, which I'm sure with no placebo, looking for side effects and adverse reactions to study drug. 50 or so participants, across the globe, who have focal onset or tonic-clonic seizures, all getting same dosage, are the first guinea pigs.
1. Anyone heard of this trial or study drug?
2. Anyone actually doing it?
3. Any other thoughts or comments?